Commit To Buy BioCryst Pharmaceuticals At $3, Earn 10.7% Using Options
October 12, 2017 at 11:55 AM EDT
Investors considering a purchase of BioCryst Pharmaceuticals, Inc. (BCRX) stock, but tentative about paying the going market price of $5.21/share, might benefit from considering selling puts among the alternative strategies at their disposal..